| 2026 | Clinicopathologic characteristics and lymph node status in the NAUTILUS clinical trial:KBCSG-21 | EJSO |
| 2026 | Impact of treatment response to neoadjuvant chemotherapy on brain metastasis patterns and breast cancer prognosis
| BREAST |
| 2025 | Ovarian Function Suppression in HR-Positive, HER2-Positive Breast Cancer: An Exploratory Analysis of the HERA Trial | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK |
| 2025 | A Randomized Trial of Sentinel Node Biopsy Omission After Neoadjuvant Systemic Therapy in Clinically Node-Negative or Selected Node-Positive Breast Cancer
| JOURNAL OF BREAST CANCER |
| 2025 | Influence of psychological factors on the benefit from interpectoral and pectoserratus plane block for recovery after partial mastectomy: a randomized controlled trial
| KOREAN JOURNAL OF ANESTHESIOLOGY |
| 2025 | Preoperative Predictors of Subsequent Breast Cancer Events Detected on Abbreviated MRI in Patients with Early-Stage Breast Cancer
| DIAGNOSTICS |
| 2025 | Patient-reported outcomes of automated breast ultrasound: considerations for screening modality selection, based on a prospective observational survey | ANNALS OF SURGICAL TREATMENT AND RESEARCH |
| 2025 | Spatial analysis of tumor immune microenvironment of TNBC with different neoadjuvant chemotherapy outcomes using multiplex Immunofluorescence
| BREAST CANCER RESEARCH |
| 2025 | Decision-Making Patterns for Clinically Node-Positive, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: Insights From a Survey of Breast Cancer Experts | JOURNAL OF BREAST CANCER |
| 2025 | Body mass index and progesterone receptor in postmenopausal ER-positive/HER2-negative breast cancer: A nation-wide study in Korean breast cancer society and the multi-institutional cohort | BREAST |
| 2025 | In Vivo Conductivity of Normal Fibroglandular Tissue Using MR Electrical Properties Tomography: A Comparison With Apparent Diffusion Coefficient
| Investigative Magnetic Resonance Imaging |
| 2025 | Clinical relevance of clinical treatment score post-5 years (CTS5) in HR-positive, HER2-positive breast cancer
| NPJ BREAST CANCER |
| 2025 | Additional prognostic value of the BCT score in ER+HER2-breast cancer patients receiving a 21-gene assay-guided adjuvant treatments
| FRONTIERS IN ONCOLOGY |
| 2025 | Pathological complete response, histologic grade, and level of stromal tumor-infiltrating lymphocytes in ER + HER2- breast cancer
| BREAST CANCER RESEARCH |
| 2025 | Adjuvant Trastuzumab Plus Pertuzumab Versus Trastuzumab Alone in Patients Achieving Pathologic Complete Response After Chemotherapy With Trastuzumab and Pertuzumab: A Retrospective Cohort Study
| CLINICAL BREAST CANCER |
| 2025 | Long-term oncologic outcome of intraoperative radiotherapy (IORT) with low-energy X-rays as a tumor-bed boost in Korean patients with breast cancer
| Cancer Treatment and Research Communications |
| 2024 | Characteristics and Prognosis of Breast Cancer Patients With Prior Hormone Replacement Therapy: Insights From the Korean Breast Cancer Society Registry
| JOURNAL OF BREAST CANCER |
| 2024 | Nipple-areolar complex sensory recovery based on incision placement after nipple-sparing mastectomy: a prospective nonrandomized controlled trial
| INTERNATIONAL JOURNAL OF SURGERY |
| 2024 | Capsular Contracture After Postmastectomy Radiation in Implant-Based Breast Reconstruction: Effect of Implant Pocket and Two-Stage Surgery
| JOURNAL OF BREAST CANCER |
| 2024 | Stromal tumor-infiltrating lymphocytes and pathologic response to neoadjuvant chemotherapy with the addition of platinum and pembrolizumab in TNBC: a single-center real-world study
| BREAST CANCER RESEARCH |
| 2024 | Clinical Relevance of TP53 Mutation and Its Characteristics in Breast Cancer with Long-Term Follow-Up Date
| CANCERS |
| 2024 | Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 h+HER2-breast cancer: a retrospective analysis
| BREAST CANCER RESEARCH |
| 2024 | Prediction of menstrual recovery patterns in premenopausal women with breast cancer taking tamoxifen after chemotherapy: an ASTRRA Substudy
| BREAST CANCER RESEARCH |
| 2024 | Immune environment of high-TIL breast cancer: triple negative and hormone receptor positive HER2 negative
| NPJ BREAST CANCER |
| 2024 | Micrometastases in axillary lymph nodes in breast cancer, post-neoadjuvant systemic therapy
| BREAST CANCER RESEARCH |
| 2024 | Psychosocial barriers and facilitators for cascade genetic testing in hereditary breast and ovarian cancer: a scoping review | FAMILIAL CANCER |
| 2024 | Loss of LPAR6 and CAB39L dysregulates the basalto-luminal urothelial differentiation program, contributing to bladder carcinogenesis
| CELL REPORTS |
| 2024 | Selective omission of sentinel lymph node biopsy in mastectomy for ductal carcinoma in situ: identifying eligible candidates
| BREAST CANCER RESEARCH |
| 2024 | Outcomes of sentinel node biopsy according to MRI response in an association with the subtypes in cN1-3 breast cancer after neoadjuvant systemic therapy, multicenter cohort study
| BREAST CANCER RESEARCH |
| 2024 | Tumor-Infiltrating Lymphocyte Level Consistently Correlates with Lower Stiffness Measured by Shear-Wave Elastography: Subtype-Specific Analysis of Its Implication in Breast Cancer
| CANCERS |
| 2024 | Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
| YONSEI MEDICAL JOURNAL |
| 2024 | Predictive Markers of Treatment Response to Neoadjuvant Systemic Therapy with Dual HER2-Blockade
| CANCERS |
| 2024 | Breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA study
| INTERNATIONAL JOURNAL OF SURGERY |
| 2024 | Elasticity Values as a Predictive Modality for Response to Neoadjuvant Chemotherapy in Breast Cancer
| CANCERS |
| 2023 | Survival Outcomes in Premenopausal Patients With Invasive Lobular Carcinoma
| JAMA NETWORK OPEN |
| 2023 | Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial | JOURNAL OF CLINICAL ONCOLOGY |
| 2023 | Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor-Positive Metastatic Breast Cancer
| CANCER RESEARCH AND TREATMENT |
| 2023 | YAP1 Expression in HR+HER2- Breast Cancer: 21-Gene Recurrence Score Analysis and Public Dataset Validation
| CANCERS |
| 2023 | Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer | JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE |
| 2023 | Prognostic impact of radiotherapy-induced-lymphopenia in patients treated with breast-conservative surgery
| SCIENTIFIC REPORTS |
| 2023 | Investigation of Factors Affecting Adherence to Adjuvant Hormone Therapy in Early-Stage Breast Cancer Patients: A Comprehensive Systematic Review
| JOURNAL OF BREAST CANCER |
| 2023 | Ki-67, 21-Gene Recurrence Score, Endocrine Resistance, and Survival in Patients With Breast Cancer
| JAMA NETWORK OPEN |
| 2023 | Comparison of Programmed Cell Death Ligand 1 Status between Core Needle Biopsy and Surgical Specimens of Triple-Negative Breast Cancer
| YONSEI MEDICAL JOURNAL |
| 2023 | Predictive biological factors for late survival in patients with HER2-positive breast cancer
| SCIENTIFIC REPORTS |
| 2023 | Radiation dose-event relationship after intraoperative radiotherapy as a boost in patients with breast cancer
| FRONTIERS IN ONCOLOGY |
| 2023 | Optimal treatment strategy for hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer patients with 1-2 suspicious axillary lymph node metastases on breast magnetic resonance imaging: upfront surgery vs. neoadjuvant chemotherapy
| FRONTIERS IN ONCOLOGY |
| 2023 | Resolution of Nonmass Enhancement Extension to the Nipple at Breast MRI after Neoadjuvant Chemotherapy: Pathologic Response and Feasibility for Nipple-sparing Mastectomy | RADIOLOGY |
| 2023 | Reprogramming anchorage dependency by adherent-to-suspension transition promotes metastatic dissemination
| MOLECULAR CANCER |
| 2023 | Complications Including Capsular Contracture in Direct-to-Implant Breast Reconstruction With Textured Anatomical Versus Smooth Round Implants: A Single Center Retrospective Analysis
| JOURNAL OF BREAST CANCER |
| 2023 | On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates
| BREAST CANCER RESEARCH |
http://orcid.org/0000-0003-0397-0005
(55184774900)
